Novavax, Inc. (NASDAQ:NVAX)’s traded shares stood at 0.54 million during the latest session, with the company’s beta value hitting 1.65. At the last check today, the stock’s price was $3.91, to imply an increase of 0.51% or $0.02 in intraday trading. The NVAX share’s 52-week high remains $11.36, putting it -190.54% down since that peak but still an impressive 9.72% since price per share fell to its 52-week low of $3.53. The company has a valuation of $547.20M, with an average of 7.47 million shares over the past 3 months.

Novavax, Inc. (NASDAQ:NVAX) trade information

After registering a 0.51% upside in the latest session, Novavax, Inc. (NVAX) has traded red over the past five days. The stock hit a weekly high of 4.48, jumping 0.51% in its intraday price action. The 5-day price performance for the stock is -9.07%, and -20.85% over 30 days. With these gigs, the year-to-date price performance is -18.54%.

Novavax, Inc. (NVAX) estimates and forecasts

Looking at statistics comparing Novavax, Inc. share performance against respective industry, we note that the company has outperformed competitors. Novavax, Inc. (NVAX) shares are -39.38% down over the last 6 months, with its year-to-date growth rate higher than industry average at 84.66% against 13.10%.

NVAX Dividends

Novavax, Inc. has its next earnings report out in May. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too. Novavax, Inc. has a forward dividend ratio of 0, with the share yield ticking at 0.00% to continue the rising pattern observed over the past year. The company’s average dividend yield trailing the past 5-year period is 0.00%.